REFERENCES
- Report on the conference on ‘Vision 2020 Planning for the Eastern Mediterranean Region,’, CairoEgypt, Dec., 2003, (WHO/EMR/PBL/ 03.1) (http://whilibdoc.who.EMR/2003/WHOPBL/03.1.pdf)
- Khandekar R, Mohammed A J, Negrel A D, Al Raiyami A. The prevalence and causes of blindness in the Sultanate of Oman: the Oman Eye study (OES). Br J Ophthalmol. 2002; 86(9)957–962, [PUBMED], [INFOTRIEVE], [CSA]
- Ministry of Health Oman Eye Health Care Manual, 2nd ed. Al Zahra Printers. 2000; 20–22
- Spooner J J, Bullano M F, Ikeda L I, et al. Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care 2002; 8(10 Suppl)S262–270, [PUBMED], [INFOTRIEVE], [CSA]
- Patel S C, Spaeth G L. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg. 1995; 26(3)233–236, [PUBMED], [INFOTRIEVE], [CSA]
- Rotchford A P, Murphy K M. Compliance with timolol treatment in glaucoma. Eye. 1998; 12(Pt 2)234–236, [PUBMED], [INFOTRIEVE], [CSA]
- Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2003. Ministry of Health, Oman 2004; 8–41
- Ministry of Health, Sultanate of Oman. Methodology Manual of the National Survey for Glaucoma in Oman. National Printers, Oman 2004; 2–6
- Fletcher R H. Patient compliance with therapeutic advice: a modern view. Mt Sinai J Med. 1989; 56(6)453–458, [PUBMED], [INFOTRIEVE], [CSA]
- De Geest S, Dobbels F, Martin S, et al. Clinical risk associated with appointment noncompliance in heart transplant recipients. Prog Transplant 2000; 10(3)162–168, [PUBMED], [INFOTRIEVE], [CSA]
- Wilson T G, Jr, Hale S, Temple R. The results of efforts to improve compliance with supportive periodontal treatment in a private practice. J Periodontol. 1993; 64(4)311–314, [PUBMED], [INFOTRIEVE], [CSA]
- Gurwitz J H, Yeomans S M, Glynn R J, et al. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care 1998; 36(3)357–369, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bloch S, Rosenthal A R, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol. 1977; 61(8)531–534, [PUBMED], [INFOTRIEVE], [CSA]
- Aziz A M, Ibrahim M I. Medication noncompliance—a thriving problem. Med J Malaysia 1999; 54(2)192–199, [PUBMED], [INFOTRIEVE], [CSA]
- Lau J T, Lee V, Fan D, et al. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol 2002; 86(10)1080–1084, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cooper J. Improving compliance with glaucoma eye-drop treatment. Nurs Times. 1996; 92(32)36–37, [PUBMED], [INFOTRIEVE], [CSA]
- Lee M D, Fechtner F R, Fiscella R G, et al. Emerging perspectives on glaucoma: highlights of a roundtable discussion. Am J Ophthalmol 2000; 130(4 Suppl)S1–11, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Granstrom P A. Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy. Arch Ophthalmol. 1985; 103(4)529–531, [PUBMED], [INFOTRIEVE], [CSA]
- Norell S E, Granstrom P A. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br J Ophthalmol. 1980; 64(2)137–141, [PUBMED], [INFOTRIEVE], [CSA]
- Chang J S, Jr, Lee D A, Petursson G, et al. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol 1991; 7(2)117–124, [PUBMED], [INFOTRIEVE], [CSA]